TIMBER PHARMACEUTICALS INC (TMBR) Forecast, Price Target & Analyst Ratings

NYSEARCA:TMBR • US8870802084

Current stock price

0.3426 USD
+0 (+0.74%)
At close:
0.3532 USD
+0.01 (+3.09%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TIMBER PHARMACEUTICALS INC (TMBR).

Forecast Snapshot

Consensus Price Target

Price Target
$11.22
+ 3,174.96% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 29, 2024
Period
Q4 / 2023
EPS Estimate
-$1.33
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$11.22
Upside
+ 3,174.96%
From current price of $0.34 to mean target of $11.22, Based on 6 analyst forecasts
Low
$11.11
Median
$11.22
High
$11.55

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for TMBR. The average price target is 11.22 USD. This implies a price increase of 3174.96% is expected in the next year compared to the current price of 0.3426.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

TMBR Current Analyst RatingTMBR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

TMBR Historical Analyst RatingsTMBR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
TMBR was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about TMBR.
In the previous month the buy percentage consensus was at a similar level.
TMBR was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-08-28HC Wainwright & Co.Downgrade Buy -> Neutral
2023-04-10HC Wainwright & Co.Reiterate Buy
2022-10-26HC Wainwright & Co.Maintains Buy
2022-08-29HC Wainwright & Co.Maintains Buy
2022-05-02HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 29, 2024
Period
Q4 / 2023
EPS Estimate
-$1.33
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
N/A
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

TMBR is expected to report earnings on 3/29/2024. The consensus EPS estimate for the next earnings is -1.33 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2024

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024
Revenue
YoY % growth
TMBR revenue by date.TMBR revenue by date.

-100.00%		890K80K
-91.01%
-100.00%
EBITDA
YoY % growth
TMBR ebitda by date.TMBR ebitda by date.
-9.63M
41.46%		-10.65M
-10.59%		-19.24M
-80.66%		N/AN/A
EBIT
YoY % growth
TMBR ebit by date.TMBR ebit by date.
-9.69M
41.31%		-10.65M
-9.91%		-19.24M
-80.66%		-16.319M
15.18%		-18.36M
-12.51%
Operating Margin
TMBR operating margin by date.TMBR operating margin by date.
N/A-1,196.63%-24,050.00%N/AN/A
EPS
YoY % growth
TMBR eps by date.TMBR eps by date.
-9.91
40.60%		N/A
-58.74%		N/A
98.77%		-5.30
-2,636.84%		-5.62
-5.96%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-1.33-1.44
-8.95%		-1.54
-22.24%		-1.37
-6.35%		-1.29
3.08%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-4.182M
-17.14%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TMBR Yearly Revenue VS EstimatesTMBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2021 2022 200K 400K 600K 800K
TMBR Yearly EPS VS EstimatesTMBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

TIMBER PHARMACEUTICALS INC / TMBR Forecast FAQ

What do analysts expect the price target to be for TIMBER PHARMACEUTICALS INC (TMBR)?

6 analysts have analysed TMBR and the average price target is 11.22 USD. This implies a price increase of 3174.96% is expected in the next year compared to the current price of 0.3426.

Can you provide the upcoming earnings date for TIMBER PHARMACEUTICALS INC?

TIMBER PHARMACEUTICALS INC (TMBR) will report earnings on 2024-03-29, after the market close.

Can you provide the consensus estimates for TIMBER PHARMACEUTICALS INC next earnings?

The consensus EPS estimate for the next earnings of TIMBER PHARMACEUTICALS INC (TMBR) is -1.33 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for TMBR stock?

The consensus rating for TIMBER PHARMACEUTICALS INC (TMBR) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.